Published in Cancer Weekly, January 11th, 2000
W.D. Erwin and colleagues from Chicago, Illinois, conducted a study to investigate whether marrow RAD, estimated using three different indirect methods, could predict actual marrow radiation toxicity. The study was conducted in NHL patients undergoing RAIT with a Y-90 labeled anti-CD20 monoclonal antibody (MAb).
Results from their study were presented at the 85th Scientific Assembly and Annual...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.